SinocellTech

IPO

Public · Beijing, China · Founded 2002

Headquarters
Beijing
Founded
2002
Business Model
B2B
Last Round
Series AJan 2017
Rounds
1
Type
Public

About

Beijing Sinocelltech Biotechnology Group Co., Ltd. (Shanghai Stock Exchange: 688520) is a Chinese biopharmaceutical company founded by Dr. Xie Liangzhi, an internationally recognized expert in biopharmaceutical research and industrialization who led China's major new drug innovation program. The company focuses on the research, development, and industrialization of monoclonal antibodies, recombinant proteins, and vaccines, with products spanning prevention (including an HPV vaccine) and treatment areas such as hemophilia and autoimmune disease.

Summary

SinocellTech is a Healthcare company based in Beijing, China, founded in 2002. Its most recent funding was a Series A round in Jan 2017. Investors include Qiming VP.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOJun 2020

Sign up to see all 2 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SinocellTech on Indexed.vc
<a href="https://indexed.vc/companies/sinocelltech"><img src="https://indexed.vc/api/badge/company/sinocelltech" alt="SinocellTech on Indexed.vc" width="260" height="76" /></a>